Key result
Cardiomyocyte single-nucleus sequencing reveals distinct transcriptional profiles separating cardiac aging from heart disease.
Why the study?
Factors predisposing aged cardiomyocytes to disease and their distinction from those underlying cardiomyopathy remain undetermined, limiting understanding of cardiac aging and heart failure development.
Observational (n=123)
Single-nucleus transcriptomic profiling reveals that while advanced age and cardiomyopathies share increased cardiomyocyte heterogeneity and specific remodeling pathways, they also possess distinct transcriptomic signatures, suggesting cardiac aging and overt disease are driven by distinct regulatory nodes.
Caution against equating aging with cardiomyopathy mechanisms; leaves open distinct nodal regulators for targeted intervention.
Age is the greatest risk factor for cardiovascular diseases, including heart failure (HF), which is a leading cause of morbidity and mortality. While left ventricular fibrosis, hypertrophy and decreased contractility are associated with cardiac aging, age is not sufficient for HF development. Despite diminished cardiomyocyte (CM) function being central to cardiac pathology, whether factors predisposing the aged CM to disease are the same or distinct from those underlying disease are not determined. To address this, we integrated our own and published single-nucleus RNA-Seq data of different cardiomyopathies and from young and old human samples and probed for unique and overlapping features. To test the utility of rodents for modelling human aging and disease, we compared human data with data from deeply phenotyped relevant rat models. We identified diverse CM substates, which were significantly altered in proportion with pathology in human and in both pathology and age in rat. In human and rat, CM exhibited substantial transcriptomic changes with age and pathology. In addition to established hallmarks of cardiomyopathy and aging, we detected etiology/age-specific differentially expressed genes/pathways and identified candidate nodal regulators underlying these changes. In human and rat, CM exhibited greater cellular and transcriptional heterogeneity in pathology and age. While rats showed substantial differences to humans, overlapping features, including increased CM heterogeneity and altered expression of genes related to epigenetic, fibrotic and hypertrophic remodelling, were also detected. Although some pathways, differentially expressed genes and trajectories are shared between age and pathology, unique aspects support age and pathology as distinct entities.
No takes yet. Share an insight, caveat, or question.
Ekhteraei‐Tousi et al. (2026) conducted an observational in Aging and Cardiomyopathies (Ischemic, Dilated, Hypertrophic) (n=123). Aging and heart disease vs. Young and age-matched non-failing hearts was evaluated on Cardiomyocyte subpopulation proportions and transcriptomic alterations/heterogeneity. Single-nucleus RNA sequencing of human and rat cardiomyocytes revealed that while aging and heart disease share increased cellular heterogeneity and fibrotic remodeling, they also maintain distinct transcriptional profiles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: